TLR4 and Parkinson disease: Fecal microbiota transplantation (FMT) protects Parkinson's disease model mice by inhibiting neuroinflammation and reducing Toll-like receptor 4/Tumor necrosis factor-alpha (TLR4/TNF-α) signaling (9).